Editorial draft — not for publication yet. Methylphenidate content needs clinical and legal review before publication. This page is general information and is not advice about an individual prescription.
In short
Incepta Pharmaceuticals’ Bangladesh product information identifies Alaradate 10 as a tablet containing methylphenidate hydrochloride 10 mg; it separately lists an oral solution. A Bangladesh product leaflet does not establish UK authorisation for a specific pack. UK methylphenidate is prescription-only and controlled, with treatment and formulation decisions made by an appropriate clinician.
For the general active-ingredient guide, continue to Methylphenidate medicine guide. This page covers Alaradate-specific product questions.
Alaradate UK product status
Incepta lists Alaradate 10 in Bangladesh. Its manufacturer leaflet does not establish UK authorisation or supply of a particular Alaradate pack. Check the exact brand, strength, formulation and manufacturer in the live MHRA product database or with a UK pharmacist; UK authorisation of another methylphenidate product does not automatically apply.
What is Methylphenidate used for in UK clinical care?
Incepta’s Bangladesh product information describes Alaradate as methylphenidate hydrochloride and lists ADHD and narcolepsy. UK guidance and product authorisations are separate: NICE recommendations concern UK ADHD care, and an overseas brand listing is not a UK prescribing recommendation.
- Incepta’s Bangladesh product leaflet lists ADHD and narcolepsy for methylphenidate
- NICE recommends methylphenidate in selected ADHD treatment pathways after appropriate assessment
- Alaradate is not an anxiety medicine, study aid, appetite suppressant or insomnia treatment
- A listed brand and 10 mg tablet strength do not establish a personal dose or UK authorisation
NICE recommends ADHD assessment and medication management by clinicians with appropriate training and expertise, followed by planned monitoring.
Methylphenidate is a Class B, Schedule 2 controlled drug in the UK. Product-specific supply and authorisation should be checked separately from ingredient-level legal status.
How does it work?
Alaradate’s stated active ingredient is methylphenidate hydrochloride, a central nervous system stimulant that affects dopamine and noradrenaline signalling involved in attention and behaviour. The response and duration depend on the person and exact formulation; a brand listing cannot establish an individual product’s contents.
Risks and possible effects
Possible methylphenidate effects
Headache, reduced appetite, stomach discomfort, restlessness and sleep difficulty may occur. Pulse, blood pressure and mood can also be affected.
Urgent warning signs
Call 999 for chest pain, seizure, collapse, severe allergic reaction or another life-threatening symptom.
Safety information
- Do not assume Alaradate has UK authorisation because methylphenidate is prescribed in the UK; verify the exact product and manufacturer.
- Do not take Alaradate unless it was prescribed and supplied to you through appropriate pharmacy safeguards.
- Tell the prescriber about heart or blood-pressure problems, mental-health conditions, epilepsy, other medicines and supplements.
- Methylphenidate must not be taken with an MAOI or within 14 days after stopping one; check other interactions with a pharmacist.
- Do not share this controlled medicine, use it for studying or appetite suppression, or drive if it affects your ability to focus safely.
Alaradate 10: brand and generic name
Incepta’s Bangladesh leaflet says an Alaradate 10 tablet contains methylphenidate hydrochloride USP 10 mg. The brand is Alaradate; the generic active ingredient is methylphenidate hydrochloride.
The leaflet separately lists an oral solution, which is a different product form. Check the exact pack rather than assuming all products under the brand have the same strength or instructions.
Alaradate and UK product status
A Bangladesh product leaflet does not establish whether a specific Alaradate pack is authorised for UK supply. UK authorisation is product-specific. Check the live MHRA product database or ask a UK pharmacist about the brand, manufacturer, strength and formulation.
Methylphenidate is prescription-only and a Class B, Schedule 2 controlled drug in the UK. This does not authenticate an overseas pack or mean it can be substituted for a UK product.
ADHD and narcolepsy: separate Bangladesh and UK context
Incepta lists ADHD and narcolepsy in its Bangladesh Alaradate product information. NICE recommends methylphenidate in selected UK ADHD treatment pathways following appropriate assessment. Product indications and treatment choices differ by jurisdiction and formulation.
NHS information says methylphenidate is sometimes used for narcolepsy; seek assessment from a clinician rather than using a stimulant to stay awake.
Not for anxiety, insomnia or studying
Methylphenidate is not an anti-anxiety medicine, sleep medicine or general study aid. It may cause sleep difficulty, appetite loss, restlessness or changes in pulse and blood pressure.
If you have ADHD and anxiety, a clinician can assess both. NICE says ADHD medication choices are generally the same when anxiety coexists, but that is not a claim that methylphenidate treats anxiety.
Read the methylphenidate generic guide
The linked generic guide covers UK ADHD recommendations, narcolepsy, anxiety and sleep questions, standard versus modified-release forms, side effects, monitoring, interactions, controlled-drug status and more.
This Alaradate page focuses on the Bangladesh brand record and the need to verify a specific pack separately.
Frequently asked questions
What is Alaradate 10?
Incepta identifies Alaradate 10 as a Bangladesh tablet containing methylphenidate hydrochloride 10 mg. Its leaflet also lists a separate oral solution.
Is Alaradate 10 available or approved in the UK?
The Bangladesh leaflet does not establish UK authorisation or current supply. Check the exact product with the MHRA or a UK pharmacist.
Can Alaradate be used for anxiety or studying?
No. Methylphenidate is not an anxiety treatment or study aid. Use it only when prescribed to you for an appropriate clinical reason.
Does Alaradate 10 mean I should take 10 mg?
No. It is the listed tablet strength, not an individual dosing instruction. Follow your own prescription.
Is Alaradate a controlled drug in the UK?
Methylphenidate is Class B and Schedule 2 in the UK. That generic status does not verify an individual Alaradate pack.
Explore the detailed alaradate (methylphenidate) guides
Each guide answers a different practical question. Advice is specific to methylphenidate and should be checked against your own product leaflet and prescription.
- What is Alaradate 10? Methylphenidate generic explained
- Is Alaradate 10 available in the UK? Status and product checks
- Alaradate 10 uses: Bangladesh product information and UK guidance
- Alaradate 10 mg: strength, formulation and prescription safety
- Alaradate side effects, interactions and urgent warning signs
- Alaradate vs methylphenidate: brand, generic and UK product differences
Sources and review
This draft was checked against the sources below on 2 October 2026. It still requires clinical and legal review before publication.
- Incepta Pharmaceuticals Limited, Bangladesh: Alaradate 10 product information from the manufacturer
- MedEx Bangladesh medicine directory: Alaradate 10 mg tablet: ingredient and manufacturer listing
- NHS: About methylphenidate and UK prescription information
- NHS: How and when to take methylphenidate
- NHS: Methylphenidate side effects and urgent warning signs
- NHS: Methylphenidate interactions with medicines and supplements
- NICE: NICE ADHD diagnosis, treatment and monitoring recommendations
- Home Office / GOV.UK: Controlled-drugs list and schedules
- MHRA: Search UK-authorised medicine product records
- MHRA: Register of authorised online medicine sellers
- NHS Specialist Pharmacy Service: Switching between modified-release methylphenidate products
Editorial status: Clinical and regulatory review required before publication.